Trial Profile
A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Teriparatide
- Indications Hypoparathyroidism; Osteoporosis
- Focus Adverse reactions
- Sponsors Entera Bio
- 06 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2014 New trial record